MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,846,107 | -30.1% | 7,692,298 | 0.0% | 2.85% | -29.2% |
Q2 2023 | $52,692,241 | -12.1% | 7,692,298 | 0.0% | 4.02% | -2.9% |
Q1 2023 | $59,923,001 | +2.4% | 7,692,298 | 0.0% | 4.14% | +25.9% |
Q4 2022 | $58,538,388 | -7.0% | 7,692,298 | -0.1% | 3.29% | +4.7% |
Q3 2022 | $62,935,000 | -15.5% | 7,703,205 | 0.0% | 3.14% | -17.9% |
Q2 2022 | $74,490,000 | -31.0% | 7,703,205 | 0.0% | 3.83% | +22.6% |
Q1 2022 | $107,999,000 | -31.3% | 7,703,205 | 0.0% | 3.12% | -1.9% |
Q4 2021 | $157,299,000 | -8.3% | 7,703,205 | 0.0% | 3.18% | +55.9% |
Q3 2021 | $171,627,000 | -1.9% | 7,703,205 | 0.0% | 2.04% | -10.5% |
Q2 2021 | $174,863,000 | – | 7,703,205 | – | 2.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $10,085,467 | 4.94% |
NEA Management Company, LLC | 7,692,298 | $52,692,241 | 4.02% |
Alphabet Inc. | 1,464,015 | $10,028,502 | 0.54% |
Avoro Capital Advisors LLC | 4,535,000 | $31,064,750 | 0.42% |
Casdin Capital, LLC | 510,882 | $3,499,542 | 0.31% |
Baker Brothers Advisors | 3,023,951 | $20,714,064 | 0.12% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $213,419 | 0.07% |
ExodusPoint Capital Management, LP | 669,495 | $4,586 | 0.04% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $193,115 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,478 | $688,274 | 0.02% |